ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Director, HEOR Analytics at Axsome Therapeutics - ApplyBlast

Associate Director, HEOR Analytics

Axsome Therapeutics

2 months ago

3.1 on Glassdoor

New York, New York, United States

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Associate Director, HEOR Analytics at Axsome Therapeutics will lead the design and execution of real-world evidence analyses using large-scale healthcare datasets. This hands‑on technical role involves developing study protocols, statistical analysis plans, and delivering high‑quality evidence to support value demonstration, payer engagement, and scientific publications.

Responsibilities

Lead development of analytical strategies for HEOR and market access
Design and execute observational real‑world evidence studies using large healthcare datasets
Translate analytical results into actionable insights for non‑technical stakeholders

Skills

Qualifications

PhD in BiostatisticsMaster’s degree in Biostatistics

About Axsome Therapeutics

axsome.com

Headquarters

New York, New York, United States

Company Size

201-500 employees

Founded

2012

View Profile

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Its pipeline and commercial programs include candidates such as AXS-05, AXS-12 and AXS-14, addressing disorders including major depressive disorder, Alzheimer’s disease agitation, migraine, narcolepsy and fibromyalgia. Axsome emphasizes innovative mechanisms of action and rigorous clinical development to deliver meaningful improvements in patient outcomes. The company is headquartered in New York City and advances programs through regulatory engagement and commercialization efforts.